Histopathology Report
Gross examination Specimen consists of a gray white nodular piece of tissue measuring about 9x6x3cm. Cut surface showed yellowish and cystic area.
Microscopic examination
Section revealed round to oval cells having vaculated cytoplasm with small, dark nuclei. Spindle cells, ectatic blood vessels and fibrous components were also seen. No malignant cells were seen. stromal tumors represent approximately 8% of ovarian neoplasms 5 and SST comprises less than 5% of sex cord stromal tumors. This relatively rare tumor characteristically differentiates itself histologically and clinically from others. The common presenting symptoms of SST include menstrual irregularity, pelvic pain and non-specific symptoms related to ovarian mass. Masculinisation or anovulation may be present in some patients as they are occasionally associated with oestrogen and rarely androgen secretion. SST usually presents in the 2nd-3rd decade of life, whereas other ovarian stromal tumors present in the 5th-6th decade of life 6 .
Microscopic picture of SST is heterogenous and contrasts with the relative homogeneity of other stromal tumors like thecoma and fibroma. Histologically it is characterized by cellular psuedolobules, prominent interlobular fibrosis, marked vascularity and dual cell population, collagen producing spindle cells, and lipid containing round or ovoid cells 7 .
The vascular sclerotic and edematous stromal changes are constant features of these tumours and relate to the local elaboration of some vascular permeability and growth factors (VPF/VEGF) 8 . Vascular tumours are also included in the differential diagnosis due to prominent vascularity, but inhibin positivity suggests the diagnosis of sclerosing stromal tumour. Sometimes massive ovarian edema may be confused with sclerosing stromal tumours but can be differentiated by preserved ovarian tissue within edematous stroma and absence of heterogeneity. Moreover, the edema in sclerosing stromal tumor is zonal in contrast to that seen in massive edema or an edematous fibroma. Sometimes the edematous stroma of these tumors contains vacuolated cells and signet ring cells (as seen in our case), which can be mistaken for signet ring cells of Krukenbergtumour of ovary. But they can be differentiated as the latter are mostly bilateral, occur usually in the 6th and 7th decades and lack pseudo-lobular pattern of sclerosing stromal tumour. Furthermore, signet ring cells of Krukenbergtumour contain mucin rather than lipid and the cells may exhibit nuclear atypia and mitotic activity. Immunohistochemical analysis in SST shows positivity for predominant smooth muscle actin and inhibin and vimentin suggesting stromal origin of sclerosing stromal tumours 9 .
Calcitonin, inhibin, CD34, and á-glutathione Stransferase (áGST) positivity has been reported to be useful to differentiate sclerosing stromal tumors from thecomas, fibromas and other sex cord stromal tumors. 
Discussion:
Sclerosing stromal tumor is a benign subtype of ovarian sex cord stromal tumor, described as a distinct entity in 1973 by Chalvardjian and Scully 4 . Sex cord Inhibin has been shown to be useful marker for ovarian sex cord stromal tumors. CD34 stains the endothelium of often dilated and branching vascular architecture and clearly distinguishes SST from thecoma and fibroma.áGST positivity within scattered cells appears to be useful in the distinction of SST from diffuse staining thecomas and no staining fibromas 10 .
On ultrasonography the appearances of SST may mimic that of malignant ovarian tumors because they show mixed pattern of cystic and solid components 11 . However color Doppler ultrasonography of SST reveals prominent vascularity in the peripheral portion and central intercystic spaces 12 . Magnetic resonance imaging is more helpful in differentiating SST from malignant ovarian tumors, which include a mass with hyperintense cystic components or a heterogenous solid mass of intermediate-to-high signal intensity on T2 weighted MRI. Dynamic contrast-enhanced images can even distinguish SST from other sex cord stromal tumors with striking early peripheral enhancement reflecting cellular areas with prominent vascular networks and an area of prolonged enhancement in inner portion of the mass representing collagenous hypocellular area. These findings are not a feature of thecomas and fibromas. This shows that MRI is useful in making a preoperative diagnosis of SST and distinguishing SST from other malignant ovarian tumors as well as other stromal tumors 13 .We stress the importance of being familiar with sclerosing stromal tumors when evaluating ovarian neoplasms in children and adolescents in order to contribute to the appropriate clinical management preventing extensive and unnecessary surgery, and preserving fertility.
Conclusion:
Due to the rarity of this particular ovarian neoplasm it is not always possible to predict the presence of this tumor preoperatively on the basis of clinical and sonographic findings. But a possibility of sclerosing stromal tumor should be kept in young patients with ovarian mass, as all of the sclerosing stromal tumors of the ovary reported in the literature were benign and were treated successfully by enucleation or unilateral ovariotomy.
